Remove Data Remove DEA Remove Extraction
article thumbnail

The Epidiolex Effect: Will Other CBD Drugs Receive FDA and DEA Approval?

Freedom Leaf

On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. Frontier Data predicts total sales of all CBD products in the U.S. Frontier Data predicts total sales of all CBD products in the U.S.

DEA 51
article thumbnail

DEA Approves MMJ International Holdings THC Shipment for Multiple Sclerosis, Huntington’s Disease Drug Development

Cannabis Law Report

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD.

DEA 66
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Delta-8 Study Finds Products Used More In States Without Legal Cannabis

Veriheal

Two methods are employed to process delta-8: one involves the chemical conversion of CBD into delta-8 and delta-9, while the other entails extracting natural delta-8 THC from hemp plants. Since delta-8 is so unpopular in states with legal cannabis, the data suggests that it is often less appealing to consumers than actual weed.

article thumbnail

What Happened to Hemp?

Canna Law Blog

I did my best to confirm Beau’s statement and was reminded of how challenging it has always been to aggregate data in this space. The study with 2017 data contains a disclaimer that “not all States reported data on the same basis.” Also, the 2017 data includes acreage for “approved” and not exclusively “cultivated”, hemp.

Hemp 91
article thumbnail

Clever Leaves and Biopharmaceutical Research Company to Partner for Landmark Cannabis Research Study in Collaboration with the University of California, Davis

Cannabis Law Report

The University of California, Davis (“UC Davis”), through an accepted research sponsorship from BRC, will lead the extraction and analysis of DNA to elucidate genetic variants taken from various genetic lines of Cannabis sativa. The UC Davis scientists will also test new approaches to extract RNA from dried material.

article thumbnail

Press Release: ACS Laboratory Launches Comprehensive Hemp Compliance Testing Panel

Cannabis Law Report

Using the data collected, ACS Laboratory extracted the strictest requirements per category to create the National Hemp Testing Panel and corresponding Certificate of Analysis. With that research, they created elaborate matrices to compare each mandate.

article thumbnail

Analysts Envision a $33.2 Billion Medical Cannabis Market By 2027

Veriheal

D espite the Drug Enforcement Agency’s (DEA) announcement in May that it would soon start reviewing grower applications for research purposes, cannabis research continues to be tightly restricted. This is according to recent data from a report published by Market Research Future (MRT) – a pioneer in market analysis.